Top drug distributors in talks to settle opioid litigation for $18 billion, report says

Business

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.

The potential settlement, according to the Wall Street Journal, would require McKesson Corp., AmerisourceBergen Corp. and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson is also involved in the discussions to pay extra money, the WSJ reported, citing people familiar with the discussions. 

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

Hoping to save on your 2019 taxes? Time is running out
How You Can Buy A Home In New Zealand Even If You Aren’t A Resident
Shou Sugi Ban: A Popular New Old Technique For Treating Wood
3,929-Acre Hub And Homestead In Central New York Is On The Market For $65 million
Here’s The Latest On The Most Expensive Neighborhoods For Apartment Renters

Leave a Reply

Your email address will not be published. Required fields are marked *